drugset / Trial / NCT00221481

An Evaluation of Divalproex vs. Olanzapine for Alcohol Abuse Relapse Prevention in Patients With Bipolar Disorder

NCT00221481 ↗

RandomizedSingle-groupSingle-blindTreatment

Summary

This study will evaluate how effective mood stabilizers are in the treatment of bipolar disorder with comorbid alcoholism

Timeline

Start
—
Primary completion
—
Completion
2006-03

Outcome

Outcome not reported

Stopped (Enrollment): “Lack of recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject Divalproex Sodium Small molecule 2500 mg —
Subject Olanzapine Small molecule 20 mg —

Indications